I think so too. Doing this would fund the core trials 100% owned by ACW. Might be something the new CEO can help with.
Ann: Actinogen appoints Dr Steven Gourlay as CEO, page-129
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $79.51M | |||
| Open | High | Low | Value | Volume |
| 2.6¢ | 2.9¢ | 2.5¢ | $504.8K | 18.89M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 7589320 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 953289 | 2 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| ACW (ASX) Chart |